• Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Kun Wha Pharmaceutical Co Ltd

+ Add to Watchlist

002250:KS

19,350 KRW 50 0.26%

As of 02:03:37 ET on 04/18/2014.

Snapshot for Kun Wha Pharmaceutical Co Ltd (002250)

Open: 19,500 Day's Range: 19,250 - 19,600 Volume: 7,062
Previous Close: 19,400 52wk Range: 15,800 - 28,550 1-Yr Rtn: +0.78%

Stock Chart for 002250

No chart data available.
  • 002250:KS 19,350
  • 1D
  • 1M
  • 1Y
19,400
Interactive 002250 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002250

Current P/E Ratio (ttm) 162.6050
Estimated P/E(-) -
Relative P/E vs. KOSPI 6.5282
Earnings Per Share (ttm) 119.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 94,621.23
Shares Outstanding (M) 4.89
30 Day Average Volume 17,409
Price/Book (mrq) 0.9904
Price/Sale (ttm) 1.3192
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002250

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 002250

Kun Wha Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, develops, manufactures, and markets drugs such as anti-inflammatory agents, antibiotics, antifungal agents, and remedies for the alimentary and cardiovascular systems.

Lee Joo-HyungCEO/Rep DirectorWilhelm Robert VishwaExecutive Director
Divya PatelExecutive DirectorKevin Michael BainExecutive Director
More Company Profile & Key Executives for 002250

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil